252 related articles for article (PubMed ID: 24686169)
1. NF-κB gene signature predicts prostate cancer progression.
Jin R; Yi Y; Yull FE; Blackwell TS; Clark PE; Koyama T; Smith JA; Matusik RJ
Cancer Res; 2014 May; 74(10):2763-72. PubMed ID: 24686169
[TBL] [Abstract][Full Text] [Related]
2. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
[TBL] [Abstract][Full Text] [Related]
4. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
5. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
6. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
Jeong JH; Park SJ; Dickinson SI; Luo JL
Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
[TBL] [Abstract][Full Text] [Related]
8. ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1.
Mak P; Li J; Samanta S; Mercurio AM
Oncotarget; 2015 Nov; 6(37):40247-54. PubMed ID: 26450901
[TBL] [Abstract][Full Text] [Related]
9. NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression.
McCall P; Bennett L; Ahmad I; Mackenzie LM; Forbes IW; Leung HY; Sansom OJ; Orange C; Seywright M; Underwood MA; Edwards J
Br J Cancer; 2012 Oct; 107(9):1554-63. PubMed ID: 23093296
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer.
Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Eto M
Endocr Relat Cancer; 2017 Apr; 24(4):171-180. PubMed ID: 28223364
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
12. HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis.
Kim YR; Kim IJ; Kang TW; Choi C; Kim KK; Kim MS; Nam KI; Jung C
Oncogene; 2014 Sep; 33(37):4558-67. PubMed ID: 24096478
[TBL] [Abstract][Full Text] [Related]
13. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).
Garg R; Blando J; Perez CJ; Wang H; Benavides FJ; Kazanietz MG
J Biol Chem; 2012 Oct; 287(44):37570-82. PubMed ID: 22955280
[TBL] [Abstract][Full Text] [Related]
14. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
[TBL] [Abstract][Full Text] [Related]
15. Determining the prognostic significance of IKKα in prostate cancer.
Montes M; MacKenzie L; McAllister MJ; Roseweir A; McCall P; Hatziieremia S; Underwood MA; Boyd M; Paul A; Plevin R; MacKay SP; Edwards J
Prostate; 2020 Oct; 80(14):1188-1202. PubMed ID: 33258506
[TBL] [Abstract][Full Text] [Related]
16. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
[TBL] [Abstract][Full Text] [Related]
17. Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.
Jin R; Sterling JA; Edwards JR; DeGraff DJ; Lee C; Park SI; Matusik RJ
PLoS One; 2013; 8(4):e60983. PubMed ID: 23577181
[TBL] [Abstract][Full Text] [Related]
18. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
Deeb D; Jiang H; Gao X; Hafner MS; Wong H; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
Mol Cancer Ther; 2004 Jul; 3(7):803-12. PubMed ID: 15252141
[TBL] [Abstract][Full Text] [Related]
19. Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer.
Nouri M; Massah S; Caradec J; Lubik AA; Li N; Truong S; Lee AR; Fazli L; Ramnarine VR; Lovnicki JM; Moore J; Wang M; Foo J; Gleave ME; Hollier BG; Nelson C; Collins C; Dong X; Buttyan R
Clin Cancer Res; 2020 Apr; 26(7):1678-1689. PubMed ID: 31919137
[TBL] [Abstract][Full Text] [Related]
20. E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.
Ren Z; Kang W; Wang L; Sun B; Ma J; Zheng C; Sun J; Tian Z; Yang X; Xiao W
Mol Cancer; 2014 Apr; 13():84. PubMed ID: 24742333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
